文献速递肝胆胰外科围术期管理与 ERAS

围术期液体治疗对原位肝移植术后早期肺部并发症的影响

[The effect of perioperative fluid therapy on early postoperative pulmonary complications after orthotopic liver transplantation].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2019-01-01

回顾性分析132例经典原位肝移植患者,术后7天内肺部并发症发生率为54.5%。多因素分析显示术中红细胞输注>10 U和术后72小时累积液体输注>12 L是肺部并发症的独立预后因素,且并发症组2年累积生存率更低。

要点

  • 肝移植术后7天内肺部并发症发生率达54.5%。
  • 术中红细胞输注>10 U增加肺部并发症风险(OR=3.55)。
  • 术后72小时累积液体输注>12 L增加肺部并发症风险(OR=2.98)。

核心结论

  • 术中输注红细胞过多和术后72小时内累积液体输注量>12 L是肝移植术后肺部并发症的独立预后因素。
  • 发生肺部并发症的患者2年累积生存率低于无肺部并发症患者。

研究设计与样本

  • 回顾性分析2016年4月至2017年12月西安交通大学第一附属医院132例经典原位肝移植患者的临床资料。
  • 男性96例,女性36例,年龄(47.3±9.6)岁(范围:24~69岁)。
  • 根据术后7天内ICU临床表现、实验室及影像学检查结果分为肺部并发症组和无肺部并发症组。
  • 采用单因素及多因素Logistic回归分析围术期指标与肺部并发症的关联,Kaplan-Meier法估计2年累积生存率。

主要发现

  • 随访期间11例患者死亡,术后7天内肺部并发症发生率为54.5%(72/132)。
  • 肺部并发症构成:仅胸腔积液34例,仅肺水肿6例,仅肺炎3例,胸腔积液+肺炎4例,胸腔积液+肺水肿15例,胸腔积液+肺不张6例,胸腔积液+肺水肿+肺炎4例。
  • 单因素分析显示终末期肝病模型评分、手术时间、输注液体总量、血制品输入量、红细胞输注量、出血量、血浆输注量、术后24、48、72小时累积液体输注量均为预后因素(P<0.05)。
  • 3天中至少2天液体平衡≤-500 ml为保护性因素。
  • 多因素分析显示术中红细胞输注量>10 U(OR=3.55,95% CI:1.35~9.26,P=0.010)和术后72小时内累积液体输注量>12 L(OR=2.98,95% CI:1.14~7.80,P=0.026)是独立预后因素。

临床怎么用

  • 肝移植围术期应关注术中红细胞输注量,避免超过10 U。
  • 术后72小时内应控制累积液体输注量,避免超过12 L。
  • 术后早期可考虑实现液体负平衡(≤-500 ml)以降低肺部并发症风险。

局限性

  • 本研究为单中心回顾性分析,样本量132例。
  • 肺部并发症诊断基于ICU临床表现、实验室及影像学检查,可能存在信息偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the effect of perioperative fluid therapy on early postoperative pulmonary complication (PPC) after orthotopic liver transplantation (OLT). Methods: The clinical data of 132 patients who underwent OLT in the First Affiliated Hospital of Xi'an Jiaotong University from April 2016 to December 2017 were analyzed retrospectively. These patients included 96 males and 36 females, aged (47.3±9.6) years (range: 24-69 years). Based on the clinical manifestations, laboratory and imaging findings of patients in ICU and PPC occurrence within 7 days after OLT surgery, the patients were divided into 2 groups: non-PPC group and PPC group. Univariate and multivariate logistic regression analyses were used to evaluate the association between perioperative variables and PPC. The Kaplan-Meier method was used to estimate cumulative survival of recipients with or without PPC within 2-years. Results: During the follow-up, 11 patients (8.3%) died and 72 patients (54.5%) developed PPC after operation. There were 34 cases, 6 cases, 3 cases, 4 cases, 15 cases, 6 cases and 4 cases of only pleural effusion, only pulmonary edema, only pneumonia, pleural effusion with pneumonia, pleural effusion with pulmonary edema, pleural effusion with atelectasis, and pleural effusion with pneumonia and pneumonia in PPC, respectively. Univariate analysis showed that the preoperative factors (model for end-stage liver disease score), the intra-operative factors (duration of surgery, total infusion volume, total blood products) and the postoperative cumulative fluid balance within the first 24 h, 48 h, and 72 h were the prognosis factors of PPC (P<0.05). At least two out of the first three postoperative days with a fluid balance of ≤-500 ml was a protective factor. Using multivariate analysis by Logistic regression, only the red blood units >10 U (OR=3.55, 95% CI: 1.35-9.26, P=0.010) and the cumulative fluid intake >12 L (OR=2.98, 95% CI: 1.14-7.80, P=0.026) within the first 72 h after operation were independent prognosis factors of PPC after OLT. Kaplan-Meier analysis showed that the cumulative survival rate was lower in PPC group than that in non-PPC group (χ(2)=6.590, P=0.01). Conclusion: Massive red blood cell transfusion and the cumulative fluid volume >12 L during perioperative 72 hours are independent prognosis factors of PPC after OLT. 目的: 探讨围手术期液体治疗对肝移植术后早期肺部并发症的影响。 方法: 回顾性分析2016年4月至2017年12月在西安交通大学第一附属医院接受经典原位肝移植术的132例患者的临床资料,男性96例,女性36例,年龄(47.3±9.6)岁(范围:24~69岁)。根据术后7 d内患者在ICU的临床表现、实验室及影像学检查结果确定是否发生肺部并发症,并将患者分为有肺部并发症组和无肺部并发症组。对两组围手术期指标进行单因素及多因素Logistic回归分析,并对受者2年内生存情况进行Kaplan-Meier生存分析。 结果: 随访期间11例患者死亡,术后7 d内肺部并发症发生率为54.5%(72/132),其中仅有胸腔积液34例,仅有肺水肿6例,仅有肺炎3例,胸腔积液+肺炎4例,胸腔积液+肺水肿15例,胸腔积液+肺不张6例,胸腔积液+肺水肿+肺炎4例。单因素分析结果显示,终末期肝病模型评分,手术时间,输注液体总量,血制品输入量,红细胞输注量,出血量,血浆输注量,术后24、48、72 h内累积液体输注量均为肝移植术后肺部并发症的预后因素(P值均<0.05),3 d中至少2 d以上液体平衡≤-500 ml为保护性因素。多因素分析结果显示,术中红细胞输注量>10 U(OR=3.55,95% CI:1.35~9.26,P=0.01),术后72 h内累积液体输注量>12 L(OR=2.98,95% CI:1.14~7.80,P=0.026)是肝移植术后肺部并发症的独立预后因素。Kaplan-Meier生存分析结果显示,肺部并发症组累积生存率低于无肺部并发症组(χ(2)=6.590,P=0.010)。 结论: 术中输注红细胞过多和术后72 h内累积液体输注量>12 L是肝移植术后肺部并发症的独立预后因素。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhang SM, An R, Liu L, et al. [The effect of perioperative fluid therapy on early postoperative pulmonary complications after orthotopic liver transplantation]. Zhonghua Wai Ke Za Zhi. 2019. PMID: 31142069. doi:10.3760/cma.j.issn.0529-5815.2019.06.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。